Viracta Therapeutics, Inc.
VIRX
$0.0175
-$0.0038-17.84%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 14.12M | 15.43M | 16.64M | 17.32M | 18.04M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 47.21M | 49.50M | 52.36M | 50.69M | 48.71M |
| Operating Income | -47.21M | -49.50M | -52.36M | -50.69M | -48.71M |
| Income Before Tax | -43.29M | -45.34M | -47.99M | -51.06M | -47.62M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -43.29 | -45.34 | -47.99 | -51.06 | -47.62 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -43.29M | -45.34M | -47.99M | -51.06M | -47.62M |
| EBIT | -47.21M | -49.50M | -52.36M | -50.69M | -48.71M |
| EBITDA | -46.77M | -49.04M | -51.88M | -50.20M | -48.28M |
| EPS Basic | -1.10 | -1.16 | -1.24 | -1.32 | -1.24 |
| Normalized Basic EPS | -0.69 | -0.73 | -0.77 | -0.83 | -0.77 |
| EPS Diluted | -1.10 | -1.16 | -1.24 | -1.32 | -1.24 |
| Normalized Diluted EPS | -0.69 | -0.73 | -0.77 | -0.83 | -0.77 |
| Average Basic Shares Outstanding | 157.09M | 156.20M | 155.36M | 154.49M | 154.02M |
| Average Diluted Shares Outstanding | 157.09M | 156.20M | 155.36M | 154.49M | 154.02M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
